Moreover, type I IFNs, particularly IFN-α, have also recently emerged as key molecules in the etiology of systemic lupus erythematosus (SLE), which is regarded as the prototype systemic autoimmune disease [48–52], thus confirming type I IFNs’ involvement in general autoimmunity. The gene discussed is IFNA1; the disease is systemic lupus erythematosus.